These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16611000)

  • 21. Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.
    Friede M; Aguado MT
    Adv Drug Deliv Rev; 2005 Jan; 57(3):325-31. PubMed ID: 15560944
    [No Abstract]   [Full Text] [Related]  

  • 22. Cancer Vaccines, Adjuvants, and Delivery Systems.
    Paston SJ; Brentville VA; Symonds P; Durrant LG
    Front Immunol; 2021; 12():627932. PubMed ID: 33859638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microparticles for intranasal immunization.
    Vajdy M; O'Hagan DT
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):127-41. PubMed ID: 11516784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in adjuvants for vaccines against infectious diseases.
    O'Hagan DT; MacKichan ML; Singh M
    Biomol Eng; 2001 Oct; 18(3):69-85. PubMed ID: 11566599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery systems and adjuvants for oral vaccines.
    Lavelle EC; O'Hagan DT
    Expert Opin Drug Deliv; 2006 Nov; 3(6):747-62. PubMed ID: 17076597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in vaccine adjuvants for infectious diseases.
    Singh M; Srivastava I
    Curr HIV Res; 2003 Jul; 1(3):309-20. PubMed ID: 15046255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems.
    Wang X; Wang N; Li N; Zhen Y; Wang T
    Hum Vaccin Immunother; 2016 Aug; 12(8):2075-2089. PubMed ID: 27159879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
    Denis F; Alain S; Ploy MC
    Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in vaccine adjuvants for systemic and mucosal administration.
    O'Hagan DT
    J Pharm Pharmacol; 1998 Jan; 50(1):1-10. PubMed ID: 9504429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New strategies for using mucosal vaccination to achieve more effective immunization.
    Walker RI
    Vaccine; 1994 Apr; 12(5):387-400. PubMed ID: 8023545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan as a novel nasal delivery system for vaccines.
    Illum L; Jabbal-Gill I; Hinchcliffe M; Fisher AN; Davis SS
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):81-96. PubMed ID: 11516781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA vaccines--challenges in delivery.
    Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
    Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal vaccine innovation.
    Jabbal-Gill I
    J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches to new vaccines.
    Mahon BP; Moore A; Johnson PA; Mills KH
    Crit Rev Biotechnol; 1998; 18(4):257-82. PubMed ID: 9887505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration.
    Gramzinski RA; Millan CL; Obaldia N; Hoffman SL; Davis HL
    Mol Med; 1998 Feb; 4(2):109-18. PubMed ID: 9508788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microparticles and nanoparticles as delivery systems for DNA vaccines.
    Cui Z; Mumper RJ
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):103-37. PubMed ID: 14584521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microparticles for the delivery of DNA vaccines.
    O'Hagan DT; Singh M; Ulmer JB
    Immunol Rev; 2004 Jun; 199():191-200. PubMed ID: 15233735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel "in-feed" delivery platform applied for oral DNA vaccination against IPNV enables high protection in Atlantic salmon (Salmon salar).
    Reyes M; Ramírez C; Ñancucheo I; Villegas R; Schaffeld G; Kriman L; Gonzalez J; Oyarzun P
    Vaccine; 2017 Jan; 35(4):626-632. PubMed ID: 28012776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal formulations: promising strategy to deliver vaccines.
    Riese P; Sakthivel P; Trittel S; Guzmán CA
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.